U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
192241192241Decitabine in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableMale Breast Cancer|Recurrent Bladder Cancer|Recurrent Breast Cancer|Recurrent Melanoma|Stage III Melanoma|Stage IV Bladder Cancer|Stage IV Breast Cancer|Stage IV Melanoma|Unspecified Adult Solid Tumor, Protocol SpecificDrug: decitabine|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00030615
192242192242Vaccine Therapy in Treating Patients With Recurrent Prostate CancerActive, not recruitingNo Results AvailableProstate CancerBiological: PSA prostate cancer vaccine|Biological: incomplete Freund's adjuvanthttps://ClinicalTrials.gov/show/NCT00030602
192243192243Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell LymphomaActive, not recruitingNo Results AvailableLymphomaDrug: bexarotene|Drug: methoxsalen|Procedure: UV light therapyhttps://ClinicalTrials.gov/show/NCT00030589
192244192244Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: cisplatin|Drug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00030576
192245192245Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverCompletedNo Results AvailableColorectal Cancer|Metastatic CancerDrug: irinotecan hydrochloride|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: radiofrequency ablationhttps://ClinicalTrials.gov/show/NCT00030563
192246192246Thalidomide in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNo Results AvailableLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsDrug: thalidomidehttps://ClinicalTrials.gov/show/NCT00030550
192247192247Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00030537
192248192248ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: gefitinibhttps://ClinicalTrials.gov/show/NCT00030524
192249192249Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct CancerTerminatedNo Results AvailableExtrahepatic Bile Duct Cancer|Liver CancerDrug: fluorouracil|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00030511
192250192250Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNo Results AvailableAdult Anaplastic Astrocytoma|Adult Anaplastic Ependymoma|Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Diffuse Astrocytoma|Adult Ependymoblastoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|AdulDrug: erlotinib hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00030498
192251192251Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00030485
192252192252Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNo Results AvailableCervical CancerDrug: pegylated liposomal doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00030472
192253192253Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaActive, not recruitingNo Results AvailableMalignant MesotheliomaDrug: cisplatin|Drug: mitomycin C|Drug: vinblastine sulfate|Drug: vinorelbine tartratehttps://ClinicalTrials.gov/show/NCT00030459
192254192254Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity CancerDrug: carboplatin|Drug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00030446
192255192255S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: gemcitabine hydrochloride|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00030433
192256192256Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: Celecoxib|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00030420
192257192257Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: Celecoxib|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00030407
192258192258Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaCompletedNo Results AvailableChildhood Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous LeukemiaDrug: imatinib mesylate|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00030394
192259192259Iododoxorubicin in Treating Patients With Primary Systemic AmyloidosisTerminatedNo Results AvailablePrimary Systemic AmyloidosisDrug: 4'-iodo-4'-deoxydoxorubicin|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00030381
192260192260Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: bortezomib|Drug: paclitaxel|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00030368
192261192261Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaWithdrawnNo Results AvailableLeukemiaDrug: homoharringtonine|Procedure: chemotherapyhttps://ClinicalTrials.gov/show/NCT00030355
192262192262Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal CancerCompletedNo Results AvailableColorectal Cancer|Kidney CancerBiological: recombinant interferon alfa|Biological: sargramostim|Biological: therapeutic autologous lymphocytes|Drug: fluorouracilhttps://ClinicalTrials.gov/show/NCT00030342
192263192263Vaccine Therapy in Treating Patients With Chronic Myelogenous LeukemiaActive, not recruitingNo Results AvailableLeukemiaBiological: recombinant 70-kD heat-shock proteinhttps://ClinicalTrials.gov/show/NCT00030303
192264192264Ultrasound in Treating Patients With Prostate Cancer Confined to the ProstateCompletedNo Results AvailableProstate CancerProcedure: high-intensity focused ultrasound ablationhttps://ClinicalTrials.gov/show/NCT00030290
192265192265High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate CancerCompletedNo Results AvailableProstate CancerProcedure: high-intensity focused ultrasound ablationhttps://ClinicalTrials.gov/show/NCT00030277
192266192266Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform NeurofibromasRecruitingNo Results AvailableNeurofibromatosis Type 1|Precancerous ConditionDrug: methotrexate|Drug: vinblastine sulfatehttps://ClinicalTrials.gov/show/NCT00030264
192267192267Supplemental Calcium in Overweight PeopleCompletedNo Results AvailableObesityDrug: Calcium supplement|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00030238
192268192268Phase 2 Evaluation of the ELAD System in the Management of Acute Liver FailureCompletedNo Results AvailableFulminant Hepatic FailureBiological: ELAD|Other: Standard of care (Control)https://ClinicalTrials.gov/show/NCT00030225
192269192269Immune Abnormalities in Sporadic Inclusion Body MyositisCompletedNo Results AvailableSporadic|Inclusion Body|Myositishttps://ClinicalTrials.gov/show/NCT00030212
192270192270Brain Control of BlinkingCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00030199

* Görseller ve İçerik tekif hakkına sahip olabilir